This site is intended for health professionals only!

Published on 26 April 2010

Share this story:
Twitter
LinkedIn

FDA nod for birth control pill

teaser

The Food and Drug Administration (FDA) has given the go-ahead for Glenmark Generics to sell its contraceptive drug Norethindrone in the US.

The product, the company’s version of NOR-QD has been approved in 0.35mg form.

Distribution is expected to commence immediately, with the treatment being marketed under the name Heather.

Glenmark chief executive officer Terrence Coughlin said: “This is a milestone in the evolving history of Glenmark Generics. Heather represents our first launch of an oral contraceptive in the United States and the first FDA approval on a product out of our hormone facility located in Goa, India.”

The firm, a generic drug specialist, has a number of products awaiting FDA approval, in addition to several treatments in various stages of development.

Copyright Press Association 2010
Glenmark Generics



Most read




Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Share this story:
Twitter
LinkedIn